Filling the need for trusted information on national health issues…

Clinical Research/R&D

  • Your Selections:

Refine Results

date

Tags

Sanofi Pasteur’s Dengue Vaccine Enters Phase III Trial In Australia

Sanofi Pasteur, the vaccines division of the pharmaceutical group Sanofi-Aventis, on Thursday announced the company had begun testing its dengue fever vaccine in a Phase III clinical trial in Australia, Dow Jones/Wall Street Journal reports. “Sanofi-Aventis already performed earlier clinical tests on children and adults with the vaccine in the U.S., Asia and Latin America,” Dow Jones/Wall Street Journal adds (Landauro, 11/4).

Pharma In Asia-Pacific Region Becomes More Active In R&D, Study Finds

In recent years, pharmaceutical companies in the Asia-Pacific region have ramped up their clinical trial activity, patent challenges of brand name drugs and their development of new products, according to report released Tuesday by CMR International, a Thomson Reuters business, Reuters reports.

Also In Global Health News: WFP In North Korea; Maternal Health In Indonesia; Possible Vaccine Contamination; GM Mosquitoes In Malaysia; Mobile Micro-Insurance In Kenya

World Food Programme Director Visits North Korea, Tours Food Factory U.N. World Food Programme (WFP) Executive Director Josette Sheeran and former U.S. Special Envoy Jack Pritchard arrived in North Korea Tuesday, Agence France-Presse reports (11/2). The visit is WFP’s “first top-level visit to the communist country in nearly 10 years,” the…

Malaria Drug Artesunate Found More Effective Than Quinine At Preventing Severe Falciparum Malaria Deaths In Children, Study Says

Researchers found that the death rate among children diagnosed with severe falciparum malaria was almost one-fourth lower when they received the drug artesunate rather than the standard treatment of quinine, according to research which was presented at the American Society for Tropical Medicine and Hygiene over the weekend and published Monday in the Lancet, HealthDay News/U.S. News and World Report writes. The results have the potential to change the WHO’s malaria treatment recommendations for children, according to the article (11/6).

Also In Global Health News: Pakistan Flood Relief; Blood Pressure Reader

U.S. Gives $90M To WFP For Pakistan Flood Relief A $90 million donation from the U.S. to the U.N. World Food Program (WFP) “will help prevent a reduction in food aid to millions of people affected by the recent catastrophic floods in Pakistan,” the Associated Press of Pakistan reports. “The U.S.…

New York Times Examines HIV Prevention Products Undergoing Clinical Trials

The New York Times examines several products being studied in clinical trials that researchers hope will one day prevent sexual transmission of HIV. The newspaper describes the ongoing trials of a vaginal microbicide gel containing the antiretroviral tenofovir which was found to reduce the risk of HIV infection in women by 39 percent, writing, “[o]ther clinical trials will report their results in 2011 and 2012 and, if all goes well, researchers hope to have a product or two ready to enter the market by 2013.”

To Reduce Spread Of HIV/AIDS, IFRC Calls For More Focus On IDU Programs

Ahead of World AIDS Day, the International Federation of the Red Cross on Friday released a report (.pdf) calling for governments around the world to do more to help stop the spread of HIV/AIDS among populations of injecting drug users (IDUs), the Associated Press reports (Heilprin, 11/25).

Also In Global Health News: Rice Research Initiative; Kala Azar In Sudan; R&D In Developing Countries; Indian Measles Vaccination Campaign

Global Rice Research Initiative Launched At International Rice Congress “The world’s leading rice research institutions are joining forces to improve rice yields and breed improved varieties … to help to secure future affordable food supplies for the world’s poorest people,” Nature News writes in an article that examines the “$600…

NPR Reports On Dengue Vaccine Progress

NPR’s “SHOTS” blog examines the growing interest of pharmaceutical companies to develop a vaccine to protect against the dengue virus.

The Henry J. Kaiser Family Foundation Headquarters: 2400 Sand Hill Road, Menlo Park, CA 94025 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/KaiserFamFound

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in Menlo Park, California.